These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35948326)

  • 21. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN; Lee HW; Cho JY; Suk K
    Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.
    Kim HS; Kim JH; Seo YM; Chun YH; Yoon JS; Kim HH; Lee JS; Kim JT
    Ann Allergy Asthma Immunol; 2017 Nov; 119(5):441-445. PubMed ID: 28866306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered Serum Phospholipids in Atopic Dermatitis and Association with Clinical Status.
    Sakai T; Herrmann N; Maintz L; Nümm TJ; Welchowski T; Claus RA; Gräler MH; Bieber T
    JID Innov; 2022 Mar; 2(2):100092. PubMed ID: 35199091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh.
    Nagata A; Kazi T; Akter Z; Nody FA; Khan MS; Shahriar ASM; Islam MS; Nakagawa T; Inui S
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-dimensional electrophoretic profiling of atopic dermatitis in primary cultured keratinocytes from patients.
    Park YD; Jang HS; Kim SY; Ko SK; Lyou YJ; Lee DY; Paik YK; Yang JM
    Proteomics; 2006 Feb; 6(4):1362-70. PubMed ID: 16402356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
    Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
    Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.
    Leshem YA; Hajar T; Hanifin JM; Simpson EL
    Br J Dermatol; 2015; 172(5):1353-7. PubMed ID: 25580670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis.
    Chiricozzi A; Esposito M; Gisondi P; Valenti M; Gori N; Giovanardi G; Bellinato F; De Simone C; Costanzo A; Fargnoli MC; Peris K
    Dermatology; 2020; 236(4):329-335. PubMed ID: 32369808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis.
    Kato A; Kamata M; Ito M; Uchida H; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Sep; 47(9):1013-1019. PubMed ID: 32548920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.
    Paller AS; Tan JKL; Bagel J; Rossi AB; Shumel B; Zhang H; Abramova A
    Br J Dermatol; 2022 Mar; 186(3):496-507. PubMed ID: 34726270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis.
    Jacob M; Masood A; Shinwari Z; Abdel Jabbar M; Al-Mousa H; Arnaout R; AlSaud B; Dasouki M; Alaiya AA; Abdel Rahman AM
    Front Allergy; 2021; 2():774902. PubMed ID: 35386989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alefacept for moderate to severe atopic dermatitis: a pilot study in adults.
    Moul DK; Routhouska SB; Robinson MR; Korman NJ
    J Am Acad Dermatol; 2008 Jun; 58(6):984-9. PubMed ID: 18395294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity.
    Kim JE; Shin MK; Park GH; Lee UH; Lee JH; Han TY; Koh HC; Jang YH; Kim HO; Na CH; Lew BL; Ahn JY; Park CO; Seo YJ; Lee YW; Sohn SW; Park YL
    Ann Dermatol; 2019 Dec; 31(6):654-661. PubMed ID: 33911665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective.
    Chia SY; Wee LWY; Koh MJA
    Dermatol Ther; 2021 May; 34(3):e14933. PubMed ID: 33751751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis.
    Katoh N; Ohya Y; Murota H; Ikeda M; Hu X; Ikeda K; Liu J; Sasaki T; Chu AD; Teixeira HD; Saeki H
    JAAD Int; 2022 Mar; 6():27-36. PubMed ID: 34988493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting Edge of the Pathogenesis of Atopic Dermatitis: Sphingomyelin Deacylase, the Enzyme Involved in Its Ceramide Deficiency, Plays a Pivotal Role.
    Imokawa G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
    Barbier N; Paul C; Luger T; Allen R; De Prost Y; Papp K; Eichenfield LF; Cherill R; Hanifin J
    Br J Dermatol; 2004 Jan; 150(1):96-102. PubMed ID: 14746622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary lipid profile of atopic dermatitis in murine model and human patients.
    Nagata N; Hamasaki Y; Inagaki S; Nakamura T; Horikami D; Yamamoto-Hanada K; Inuzuka Y; Shimosawa T; Kobayashi K; Narita M; Ohya Y; Murata T
    FASEB J; 2021 Nov; 35(11):e21949. PubMed ID: 34591339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper and ceruloplasmin levels are closely related to the severity of preeclampsia.
    Sak S; Barut M; Çelik H; Incebiyik A; Ağaçayak E; Uyanikoglu H; Kirmit A; Sak M
    J Matern Fetal Neonatal Med; 2020 Jan; 33(1):96-102. PubMed ID: 29886772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.